Cargando…

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort

INTRODUCTION: The prevalence of antibodies to RNA polymerase III (anti-RNAP) differs among systemic sclerosis (SSc) cohorts worldwide. Previously reported associations of anti-RNAP include diffuse cutaneous disease, tendon friction rubs and renal crisis, with recent reports suggesting a close tempor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikpour, Mandana, Hissaria, Pravin, Byron, Jillian, Sahhar, Joanne, Micallef, Maree, Paspaliaris, William, Roddy, Janet, Nash, Peter, Sturgess, Alan, Proudman, Susanna, Stevens, Wendy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334664/ https://www.ncbi.nlm.nih.gov/pubmed/22189167 http://dx.doi.org/10.1186/ar3544

Ejemplares similares

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
por: Thakkar, Vivek, et al.
Publicado: (2012)

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study
por: Esposito, James, et al.
Publicado: (2016)

Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
por: Morrisroe, Kathleen, et al.
Publicado: (2022)

Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis
por: Moxey, Jayne, et al.
Publicado: (2019)

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
por: Thakkar, Vivek, et al.
Publicado: (2013)

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis
por: Metwally, Mayada, et al.
Publicado: (2019)

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study
por: Osthoff, Michael, et al.
Publicado: (2014)

Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
por: Morrisroe, Kathleen, et al.
Publicado: (2016)

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
por: Hao, Yanjie, et al.
Publicado: (2015)

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis
por: Massolino, Rose I, et al.
Publicado: (2018)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3
por: Zochling, Jane, et al.
Publicado: (2014)

Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol
por: Calderone, Alicia, et al.
Publicado: (2016)

Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies
por: Day, Jessica, et al.
Publicado: (2020)

Meloxicam-Induced Rhabdomyolysis in the Context of an Acute Ross River Viral Infection
por: Al Kindi, Mahmood, et al.
Publicado: (2012)

Myopericarditis following both BNT162b2 and NVX-CoV2373
por: Ahmad, Saima, et al.
Publicado: (2022)

47XXY and 47XXX in Scleroderma and Myositis
por: Scofield, R. Hal, et al.
Publicado: (2022)

A survey of Australian rheumatologists’ perspectives of nutrition needs in systemic sclerosis
por: Samm, De-arne A, et al.
Publicado: (2023)

Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy
por: Heddle, Robert, et al.
Publicado: (2019)

Radiotherapy for parotid IgG4‐related disease
por: Roos, Daniel E., et al.
Publicado: (2018)

The DNA polymerase III holoenzyme contains γ and is not a trimeric polymerase
por: Dohrmann, Paul R., et al.
Publicado: (2016)

Recruitment of RNA polymerase III in vivo
por: Kenneth, Niall S., et al.
Publicado: (2008)

Structure of human RNA polymerase III
por: Ramsay, Ewan Phillip, et al.
Publicado: (2020)

RNA Polymerase III, Ageing and Longevity
por: Kulaberoglu, Yavuz, et al.
Publicado: (2021)

Endobronchial obstruction in connective tissue diseases: an uncommon but life threatening complication: two case reports
por: Shah, Rushab, et al.
Publicado: (2023)

Myocardial fibrosis and arrhythmic burden in systemic sclerosis
por: Ross, Laura, et al.
Publicado: (2022)

Extragenic Accumulation of RNA Polymerase II Enhances Transcription by RNA Polymerase III
por: Listerman, Imke, et al.
Publicado: (2007)

The nuclear RNA polymerase II surveillance system targets polymerase III transcripts
por: Wlotzka, Wiebke, et al.
Publicado: (2011)

Spatial organization of transcription by RNA polymerase III
por: Haeusler, Rebecca A., et al.
Publicado: (2006)

Corrigendum: RNA Polymerase III, Ageing and Longevity
por: Kulaberoglu, Yavuz, et al.
Publicado: (2021)

Long-Range PCR Amplification of DNA by DNA Polymerase III Holoenzyme from Thermus thermophilus
por: Ribble, Wendy, et al.
Publicado: (2015)

Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort
por: Galindo-Feria, Angeles S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tce0gmdm3t57ja1mdu35pssjqb